Lexington Biosciences Inc. (LXGTF)

[Sabretooth0071]

Its not a matter of them wanting to do it, its Business and to be successful they really have no choice..
37.8 million shares isn't enough to generate R&D and working capital. An IPO would increase company worth and profitability, causing share prices to drop due to the sudden amount of new shares up for sale. Even when the HS is in Medical facilities they will still need cash. And apart from sales their SEC filings need to show positive, to interest new investors. Remember as yet there are no Institutional Investors, when there is, they will require lots of shares. Its just unrealistic for LEX to plod on with 37.8 million shares at .18. Now perhaps they will and do have a great sales force, they still have to produce the device and get paid.. And anyone whose been in Business will tell you when you start out your expenditure is higher than your Receipts.

Have a Great Day